Literature DB >> 20131226

Cardiovascular disease in patients with inflammatory rheumatic disease is associated with up-regulation of markers of inflammation in cardiac microvessels and cardiomyocytes.

Cecilia Grundtman1, Ivana Hollan, Oystein T Førre, Kjell Saatvedt, Knut Mikkelsen, Ingrid E Lundberg.   

Abstract

OBJECTIVE: Various inflammatory rheumatic diseases (IRDs) are associated with increased mortality due to cardiovascular disease. The aim of this study was to investigate heart biopsy specimens obtained from patients undergoing coronary artery bypass grafting and compare markers of inflammation and endothelial cell activation in the cardiac and skeletal muscle of patients with and those without IRD.
METHODS: Paired biopsy specimens of cardiac and skeletal muscle were obtained from 22 consecutive patients with IRD and 8 patients without IRD, all of whom were undergoing coronary artery bypass grafting. The biopsy specimens were evaluated in a blinded manner by conventional microscopy and digital image analysis for cell markers (CD3, CD4, CD8, CD68, CD163, and CD31), HLA (HLA-ABC, HLA-DR, and HLA-DQ), adhesion molecules (intercellular adhesion molecule 1 and vascular cell adhesion molecule 1), and proinflammatory cytokines (interleukin-1alpha, interleukin-1beta, and tumor necrosis factor).
RESULTS: Patients with IRD had significantly higher expression of adhesion molecules, proinflammatory cytokines, and all classes of HLA on cardiomyocytes and endothelial cells but no increase on mononuclear cells in the myocardium compared with patients without IRD. Furthermore, cardiac muscle from patients with IRD displayed significantly higher local expression of inflammation and activation of cardiac microvessels compared with skeletal muscle from the same patients.
CONCLUSION: Patients with cardiovascular disease had increased expression of adhesion molecules, HLA, and proinflammatory cytokines in heart tissue, indicating local inflammation involving microvessels and cardiomyocytes that could play a role in the pathogenesis of cardiovascular disease. The more pronounced changes in patients with IRD compared with patients without IRD might contribute to the increased risk of cardiovascular disease and premature death in patients with IRD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20131226     DOI: 10.1002/art.27264

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

1.  Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis.

Authors:  Isabelle Amigues; Aylin Tugcu; Cesare Russo; Jon T Giles; Rachelle Morgenstein; Afshin Zartoshti; Christian Schulze; Raul Flores; Sabahat Bokhari; Joan M Bathon
Journal:  Arthritis Rheumatol       Date:  2019-02-28       Impact factor: 10.995

2.  Increased rat neonatal activity influences adult cytokine levels and relative muscle mass.

Authors:  Bryce Buchowicz; Tiffany Yu; Dwight M Nance; Frank P Zaldivar; Dan M Cooper; Gregory R Adams
Journal:  Pediatr Res       Date:  2010-11       Impact factor: 3.756

3.  A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis.

Authors:  John M Davis; Keith L Knutson; Michael A Strausbauch; Cynthia S Crowson; Terry M Therneau; Peter J Wettstein; Veronique L Roger; Eric L Matteson; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2011-06

4.  Identification of streptococcal m-protein cardiopathogenic epitopes in experimental autoimmune valvulitis.

Authors:  Christine A Kirvan; Jeffrey E Galvin; Silvia Hilt; Stanley Kosanke; Madeleine W Cunningham
Journal:  J Cardiovasc Transl Res       Date:  2013-12-18       Impact factor: 4.132

5.  Inflammatory cell infiltrates in the heart of patients with coronary artery disease with and without inflammatory rheumatic disease: a biopsy study.

Authors:  Jacqueline K Andersen; Ingvild Oma; Richard A Prayson; Ingjerd Lien Kvelstad; Sven Martin Almdahl; Morten Wang Fagerland; Ivana Hollan
Journal:  Arthritis Res Ther       Date:  2016-10-12       Impact factor: 5.156

Review 6.  Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation.

Authors:  Jianmin Chen; Lucy V Norling; Dianne Cooper
Journal:  Cells       Date:  2021-04-13       Impact factor: 6.600

7.  Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis--a population-based longitudinal follow-up study.

Authors:  Ya-Ping Huang; Yen-Ho Wang; Shin-Liang Pan
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

8.  Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers.

Authors:  Rod Balhorn; Monique Cosman Balhorn
Journal:  Oncotarget       Date:  2020-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.